3-D model of solid tumors explains cancer evolution

August 26, 2015
A three-dimensional model of a tumor showing cell types in varying colors. Credit: Bartek Waclaw and Martin Nowak

They're among the most powerful tools for shedding new light on cancer growth and evolution, but mathematical models of the disease for years have faced an either/or stand off.

Though models have been developed that capture the spatial aspects of tumors, those models typically don't study genetic changes. Non-spatial models, meanwhile, more accurately portray tumors' evolution, but not their three-dimensional structure.

A collaboration between Harvard, Edinburgh, and Johns Hopkins Universities including Martin Nowak, Director of the Program for Evolutionary Dynamics and Professor of Mathematics and of Biology at Harvard, has now developed the first model of solid tumors that reflects both their three-dimensional shape and genetic evolution. The new model explains why have a surprising number of genetic mutations in common, how driver mutations spread through the whole tumor and how drug resistance evolves. The study is described in an August 26 paper in Nature.

"Previously, we and others have mostly used non-spatial models to study cancer evolution," Nowak said. "But those models do not describe the spatial characteristics of solid tumors. Now, for the first time, we have a computational model that can do that."

A key insight of the new model, Nowak said, is the ability for to migrate locally.

"Cellular mobility makes cancers grow fast, and it makes cancers homogenous in the sense that cancer cells share a common set of mutations. It is responsible for the rapid evolution of drug resistance," Nowak said. "I further believe that the ability to form metastases, which is what actually kills patients, is a consequence of selection for local migration."

Nowak and colleagues, including Bartek Waclaw of the University of Edinburgh, who is the first author of the study, Ivana Bozic of Harvard University and Bert Vogelstein of Johns Hopkins University, set out to improve on past models, because they were unable to answer critical questions about the spatial architecture of genetic evolution.

"The majority of the mathematical models in the past counted the number of cells that have particular mutations, but not their spatial arrangement," Nowak said. Understanding that spatial structure is important, he said, because it plays a key role in how tumors grow and evolve.

In a spatial model cells divide only if they have the space to do so. This results in slow growth unless cells can migrate locally.

"By giving cells the ability to migrate locally," Nowak said, "individual cells can always find new space where they can divide.

The result isn't just faster tumor growth, but a model that helps to explain why cancer cells share an unusually high number of , and how drug resistance can rapidly evolve in tumors.

As they divide, all cells - both healthy and cancerous - accumulate mutations, Nowak said, and most are so called "passenger" mutations that have little effect on the cell.

In cancer cells, however, approximately 5 percent are what scientists call "driver" mutations - changes that allow cells to divide faster or live longer. In addition to rapid tumor growth, those mutations carry some previous passenger mutations forward, and as a result cancer cells often have a surprising number of mutations in common.

Similarly, emerges when cells mutate to become resistant to a particular treatment. While targeted therapies wipe out nearly all other cells, the few resistant cells begin to quickly replicate, causing a relapse of the cancer.

"This migration ability helps to explain how driver are able to dominate a tumor, and also why targeted therapies fail within a few months as resistance evolves," Nowak said. "So what we have is a computer for , and it's this local migration that is of crucial importance."

"Our approach does not provide a miraculous cure for cancer." said Bartek Waclaw, "However, it suggests possible ways of improving cancer therapy. One of them could be targeting cellular motility (that is local migration) and not just growth as standard therapies do."

Explore further: Cancer therapy 'tumor sanctuaries' and the breeding ground of resistance

More information: A spatial model predicts that dispersal and cell turnover limit intratumor heterogeneity, Nature, DOI: 10.1038/nature14971

Related Stories

A better way to personalize bladder cancer treatments

August 14, 2015

Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer. In early proof-of-concept research, the team took bladder ...

New plan of attack in cancer fight

July 19, 2013

New research conducted by Harvard scientists is laying out a road map to one of the holy grails of modern medicine: a cure for cancer.

Recommended for you

New inhibitor drug shows promise in relapsed leukemia

June 21, 2017

A new drug shows promise in its ability to target one of the most common and sinister mutations of acute myeloid leukemia (AML), according to researchers at the Perelman School of Medicine at the University of Pennsylvania ...

Blocking cancer—scientists find new way to combat disease

June 21, 2017

New findings published in Nature Chemical Biology show promise for finding new solutions to treat lung cancer and other deadly diseases. Kentucky continues to lead the nation in incidence and death rates from lung cancer, ...

Could certain hair dyes, relaxers raise breast cancer risk?

June 21, 2017

(HealthDay)—The safety of hair products has been debated for years. Now, new research suggests that black women who use dark hair dyes face a higher risk of breast cancer, while chemical relaxers and straighteners boost ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.